Peptide companies Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
21:06
Jun 30
Jun 30
FDA opposes peptides; peptide companies hurt
FDA recommends against adding all seven reviewed peptides to the 503A bulks list, effectively banning legal human use and killing the gray market. Real companies that entered the peptide space in anticipation of regulatory change face a serious hit.
MED
About Peptide companies Investor Commentary
Across the available history and selected sources, Buzzberg tracks Peptide companies across 1 sources: 0 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: John Coogan.